Aquavit Files Investigational New Drug Application for its Flagship Intradermal Injection of Botulinum Toxin ...Middle East

NEW YORK, April 28, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin applications, announced today that it has filed an Investigational New Drug Application with the FDA for its flagship intradermal injection of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Aquavit Files Investigational New Drug Application for its Flagship Intradermal Injection of Botulinum Toxin )

Also on site :

• '90s Bombshell, 53, Makes Bold Statement About 'Natural Aging'
• Julia Fox's Net Worth in 2025 Proves She's an It Girl
• Israel strikes Syria again, claims to have killed alleged Hamas member